A new long-acting insulin (HOE901) demonstrates less nocturnal hypoglycaemia when compared with protamine insulin in a clinical trial.

A new long-acting insulin (HOE901) demonstrates less nocturnal hypoglycaemia when compared with protamine insulin in a clinical trial.

Bibliographic Details
Main Authors:	Matthews, DR, Pfeiffer, C
Format:	Journal article
Published:	1998